Predictive Oncology Inc. (POAI) Social Stream



Predictive Oncology Inc. (POAI): $0.72

0.03 (+4.50%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add POAI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#193 of 337

in industry

PREDICTIVE ONCOLOGY INC (POAI) Price Targets From Analysts

Use the tables below to see what analysts covering PREDICTIVE ONCOLOGY INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-11-15 2 $5 $5 $5 $3.38 47.93%

The Trend in the Analyst Price Target


POAI's average price target has moved up $2 over the prior 21 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

POAI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • POAI has a lower variance in analysts' estimates than just about 100% of all US stocks.
  • In the context of all US stocks, PREDICTIVE ONCOLOGY INC's number of analysts covering the stock is higher than 2.83% of them.
  • PREDICTIVE ONCOLOGY INC's average analyst price target is higher than 11.34% of Medical Equipment stocks.
  • PREDICTIVE ONCOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 56.62% of stocks in the micro market cap category.

In the Medical Equipment industry, MLSS, ZJYL, and NDRA are the three stocks most similar to PREDICTIVE ONCOLOGY INC regarding the price target and analyst recommendation information presented here.

Is POAI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!